Alexander Gusev

Dana-Farber Cancer Institute

NIH Rank #3762
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.5M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#3,762
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.5M across 4 grants · National rank #3762.

Top grants by award amount

Alexander Gusev's NIH grant portfolio, ranked by award amount.

  • 1R01CA293091-01R01
    Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
    $689.9K
    award amount
  • 5R01CA262577-03R01
    Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
    $640.3K
    award amount
  • 7R01CA244569-05R01
    Characterizing non-coding somatic and germline variant interactions in ovarian cancer
    $614.1K
    award amount
  • 1R01HG013083-01A1R01
    Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease
    $507.2K
    award amount

Affiliations

Institutions that have administered grants for Alexander Gusev.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3762
  6. 2024
    Entered Top 25% Nationally
    Ranked #3762
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions